A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood—and it can support the cells’ growth for further analysis.
The device, believed to be the first to pair these functions, uses the advanced electronics material graphene oxide. In clinics, such a device could one day help doctors diagnose cancers, give more accurate prognoses and test treatment options on cultured cells without subjecting patients to traditional biopsies.
“If we can get these technologies to work, it will advance new cancer drugs and revolutionize the treatment of cancer patients,” said Max Wicha, M.D., Distinguished Professor of Oncology and director of the U-M Comprehensive Cancer Center and co-author of a paper on the new device, published online this week in Nature Nanotechnology.
“Circulating tumor cells will play a significant role in the early diagnosis of cancer and to help us understand if treatments are working in our cancer patients by serving as a ‘liquid’ biopsy to assess treatment responses in real time,” said co-author Dr. Diane Simeone, the Lazar J. Greenfield Professor of Surgery at the U-M Medical School and director of the Translational Oncology Program.
“Studies of circulating tumor cells will also help us understand the basic biologic mechanisms by which cancer cells metastasize or spread to distant organs—the major cause of death in cancer patients.”
Yet these cells aren’t living up to their promise in medicine because they are so difficult to separate from a blood sample, the researchers say. In the blood of early-stage cancer patients, they account for less than one in every billion cells, so catching them is tougher than finding the proverbial needle in a haystack.
“I can burn the haystack or use a huge magnet,” said Sunitha Nagrath, an assistant professor of chemical engineering, who led the research. “When it comes to circulating tumor cells, they almost look like—feel like—any other blood cell.”
On their microfluidic chip, Nagrath’s team grew dense forests of molecular chains, each equipped with an antibody to grab onto cancer cells.
Even after the cells are caught, it’s still hard to run a robust analysis on just a handful of them, the researchers say. That’s why this demonstration of highly sensitive tumor cell capture, combined with the ability to grow the cells in the same device, is so promising.
Hyeun Joong Yoon, a postdoctoral researcher in the Nagrath lab with a background in electrical engineering, was instrumental in making the microfluidic chip. He started with a silicon base and added a grid of nearly 60,000 flat gold shapes, like four-petaled flowers, each no wider than a strand of hair.
The gold flowers naturally attracted a relatively new material called graphene oxide. These sheets of carbon and oxygen, just a few atoms thick, layered themselves over the gold. This layered formation allowed the team to grow the tumor-cell-catching molecular chains so densely.
“It’s almost like each graphene has many nano-arms to capture cells,” Nagrath said.
To test the device, the team ran one-milliliter samples of blood through the chip’s thin chamber. Even when they had added just three-to-five cancer cells to the 5-10 billion blood cells, the chip was able to capture all of the cells in the sample half the time, with an average of 73 percent over 10 trials.
“That’s the highest anybody has shown in the literature for spiking such a low number of cells,” Nagrath said.
The Latest Bing News on:
Liquid biopsy
- Angle PLC Announces New Commercial Agreement with Large Pharmaon May 2, 2024 at 11:00 pm
ANGLE commissioned to develop a Parsortix-based Androgen Receptor detection assay for use in prostate cancer studies GUILDFORD, SURREY / ACCESSWIRE / / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a ...
- Sophia Genetics Announces Syndicate Bio As First Liquid Biopsy Customer In Africaon April 26, 2024 at 1:42 am
Boston, MA and Rolle, Switzerland, April 23, 2024 ndash; SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader i ...
- Liquid biopsy firm Angle signs new commercial agreement with AstraZenecaon April 24, 2024 at 1:16 am
United Kingdom-based liquid biopsy company Angle (OTCQX:ANPCY) has signed a supplier agreement with the biopharmaceutical company AstraZeneca (NASDAQ:AZN) to tailor the existing Parsortix-based DNA ...
- JCO Precision Oncology Conversationson April 16, 2024 at 5:01 pm
Dr. Christian Rolfo: Thank you very much, Rafeh. It's a pleasure to be here and discuss about liquid biopsy. Dr. Rafeh Naqash: You have a very important role in different liquid biopsy consortiums.
- There’s still no standard test to detect pancreatic cancer early. Scientists are working to change thaton April 8, 2024 at 8:31 am
Across the United States, research teams are investigating ways to spot early cases, with many turning to blood-based liquid biopsy tests. “This term ‘liquid biopsy,’ essentially ...
- An exosome-based liquid biopsy shows promise for early detection of pancreatic canceron April 7, 2024 at 5:00 pm
An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American ...
- World Health Day: Doctor Explains Impact Of Liquid Biopsy Technology On Early Cancer Detectionon April 6, 2024 at 11:55 pm
D. Hinduja Hospital & MRC, Mahim, Mumbai. Liquid biopsy is one of the methods that can help in early detection of cancer. Explaining what this is, Dr Patil said, “Liquid biopsy is the scientific ...
- Vietnam Liquid Biopsy Market Embarking on the Uncharted Mastering Deep Understanding through Observational Prowesson April 3, 2024 at 1:41 am
The Market research Reports Collection of Report Ocean has recently included the “Vietnam Liquid Biopsy Market” Size, Scope, and Forecast 2024-2032 report. This report, prepared by industry experts ...
The Latest Google Headlines on:
Liquid biopsy
[google_news title=”” keyword=”Liquid biopsy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Diagnosing cancers
- Clarkson’s Farm star Gerald Cooper ‘terrified’ after cancer diagnosison May 2, 2024 at 7:34 pm
Clarkson’s Farm star Gerald Cooper has been diagnosed with prostate cancer, with Jeremy Clarkson revealing his co-star was "terrified" and "desperately upset". Gerald has undergone an operation, ...
- Commentary: A time to fight: How one woman is using her cancer diagnosis to bring awareness to otherson May 2, 2024 at 6:26 pm
On Valentine’s Day, 2024, I was diagnosed with cancer. “You have sarcoma of the bone, and it’s spread to your lungs,” my oncologist said. Sign up for our Daily eBlast to get coverage on Black ...
- Clarkson’s Farm star diagnosed with cancer in crushing season 3 momenton May 2, 2024 at 5:07 pm
‘Gerald’s got cancer. Oh s**t,’ Jeremy told the camera crew. In the following episode, Jeremy said Gerald had been diagnosed with prostate cancer. Gerald and Jeremy have a sweet bond (Picture: Prime ...
- Coping in the aftermath of a cancer diagnosison May 2, 2024 at 9:13 am
Receiving a cancer diagnosis can be one of the most stressful, pivotal moments in an individual’s life. Fred Hutch social psychologist and health communication researcher, Megan J. Shen, PhD, shares ...
- Susan G. Komen executive director diagnosed with breast cancer againon May 1, 2024 at 7:05 pm
Her first diagnosis was 14 years ago. She fought it and beat it. Now, the executive director of Susan G. Komen Wisconsin has breast cancer again.
- Novel Blood Biomarkers Show Potential for Early Liver Cancer Diagnosison May 1, 2024 at 5:00 pm
“Liver cancer rates are rapidly increasing, and liver cancer has a high mortality rate, but if we can diagnose it early, therapeutic interventions can be potentially curative,” lead author Xinyuan ...
- Prince William Shares First Update On Kate Middleton After Her Cancer Diagnosison May 1, 2024 at 10:13 am
William and Kate recently celebrated a happy milestone together, marking their 13th wedding anniversary on Monday with a never-before-seen photo. The black-and-white portrait was taken by photographer ...
- Philadelphia Medical Malpractice Attorney Weitz Delayed Cancer, Stroke Diagnosison May 1, 2024 at 9:38 am
The Weitz Firm, LLC, a premier Philadelphia legal practice, prioritizes medical malpractice cases, focusing on delayed cancer and stroke ...
- King Charles Details How He Felt Upon Receiving His Cancer Diagnosison May 1, 2024 at 8:54 am
Along with Charles, Princess Kate was also diagnosed with cancer around the same time, though she didn't publicly share the news until the end of March. She is currently undergoing "preventative ...
- King Charles tells of cancer diagnosis shock on return to dutieson May 1, 2024 at 8:34 am
The king has been receiving treatment for an undisclosed form of cancer since early February, and on Friday it was announced he would be returning to public-facing duties.
The Latest Google Headlines on:
Diagnosing cancers
[google_news title=”” keyword=”diagnosing cancers” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]